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Abstract Calu-6 cells were characterized for studying the 
transcriptional regulation of the human renin gene. Analysis of 
as-acting elements of the renin promoter showed the highest 
activity within the first 582 bp in serum-free conditions and of the 
892 bp in the presence of serum. cAMP activates renin mRNA 
synthesis parallel to renin production (20-fold increase) as well 
renin promoter activity (2-fold). cAMP response element and the 
(—77 to —67) element are both necessary for activation of the 
renin promoter but do not act independently. Functional analysis 
of Intron A revealed the presence of a silencer specific to renin-
producing cells. 
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1. Introduction 
Renin (EC 3.4.23.15) is an aspartyl protease which plays a 
major role in blood pressure control and electrolytic regula-
tion by catalyzing the first and rate-limiting step of the renin-
angiotensin system, i.e. the conversion of angiotensinogen to 
angiotensin I. Juxtaglomerular (JG) cells of the kidney are the 
primary source of circulating renin [1,2]. Recently, Petrovic et 
al. [3] showed that As4.1 cells, an immortalized cell line iso-
lated from transgenic mice kidneys obtained by targeted onco-
genesis, express mouse renin and regulate the mouse promoter 
in transient transfection experiments. Nevertheless, the lack of 
an established human JG cell line has greatly hampered the 
study of the transcriptional regulation of the human renin 
gene. 
The renin gene, from human or rodent origin, is also ex-
pressed in several extra-renal sites [4] as for the other essential 
components of the renin-angiotensin system, thereby raising 
the hypothesis of differential transcriptional regulations in 
these different tissues. Primary cultures of human renin-ex-
pressing chorionic cells [5,6] have been the model of choice 
to study the transcriptional regulation of the human renin 
gene. Our studies have enabled the identification of c«*-regu-
latory elements of the proximal promoter and ^raws-acting 
factors involved in basal and cyclic AMP (cAMP)-induced 
transcription in these cells [7,8]. 
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Renin has been shown to be expressed in the lung in trans-
genic mice [9] and in rare cases of hypertension due to renin-
secreting pulmonary tumors [10-12]. Finally, recent studies by 
Lang et al. [13] showed that Calu-6 cells, a pulmonary carci-
noma cell line express human renin mRNA and are a poten-
tially interesting model for studying the regulation of the tran-
scription of the gene. 
The aim of this study was to elucidate the mechanisms 
controlling renin gene expression in Calu-6 cells. We deter-
mined the rate of endogenous human renin secretion and gene 
transcription as well as the cù-acting elements of the proximal 
promoter involved in basal and cAMP-induced transcription. 
Since sequences downstream from the transcription start site, 
particularly within the first intron, have been described which 
regulate the expression of various other genes in transient 
transfection experiments [14,15] and in transgenic studies 
[16], the role of intron A on human renin gene transcriptional 
regulation was studied ex vivo. In addition, the regulation by 
cAMP of human renin secretion and gene expression was 
studied in this model and compared to results previously pub-
lished using primary cultures of chorionic cells [17] and jux-
taglomerular cells [18]. The regulation of proximal promoter 
activity by cAMP was also investigated as contradictory re-
sults were published by the same group [19,20]. 
2. Materials and methods 
2.1. Cell culture 
The Calu-6 cell line was obtained from the ATCC (HTB 56) and 
grown in Minimal Essential Medium (MEM) with Earle's salts sup-
plemented with sodium pyruvate, non-essential amino acids, 1 mM 
glutamine and 10% fetal calf serum (FCS). 
2.2. Renin immunostaining 
Indirect immunofluorescence studies were performed as described 
previously [21]. Calu-6 cells, incubated or not in the presence of 10~6 
M forskolin, were grown in labtek coverslip flasks, rinsed in Tris-
buffered saline (TBS: 0.1 M Tris and 0.25 M NaCl) solution, fixed 
in 4% paraformaldehyde with 3% sucrose for 45 min at room temper-
ature and rinsed in TBS. The cells were then incubated for 1 h with 
the primary antibody R15 (polyclonal renin antiserum). R15 was used 
at a dilution of 1:50. As a negative control, cells were incubated with 
preimmune serum. Cells were then rinsed in TBS and incubated for 1 h 
with a fluorescinated anti-rabbit immunoglobulin antibody at a dilu-
tion of 1:10. 
2.3. Determination of renin content and renin secretion 
Calu-6 cells were grown in 25 cm2 flasks. At confluency, culture 
medium was saved for renin secretion measurement and cells were 
rinsed 3 times with PBS. Cells were collected by scraping, resuspended 
in 500 ul of PBS and sonicated twice for 30 s at 4°C. An aliquot was 
removed for total protein quantification before renin measurement. 
Total renin (prorenin and active renin) was measured by ELISA as 
described by Ménard et al. [22]. 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / /S0014-5793(97)00332-3 
178 5. Germain et al.lFEBS Letters 407 (1997) 177-183 
2.4. Measurement of human renin mRNA by quantitative RTIPCR 
Calu-6 cells were plated on to 12-well plates. At confluency, cells 
were washed twice with PBS and then incubated in 750 ul of serum-
free medium for 24 h. Forskolin (10~5 M) was added after renewal of 
serum-free medium and cells were incubated for 24 h. Then, culture 
medium was saved for renin measurement and cells were washed once 
with ice-cold PBS, lysed by the addition of 100 ul of an ice-cold buffer 
containing 2% Nonidet (NP40), 10 mM Tris-HCl (pH 8), 10 mM 
NaCl, 3 mM MgCl2, and 0.7% (v/v) ß-mercaptoethanol to each cul-
ture well and shaked for 10 min. Cell nuclei were removed by centri-
fugation at 12 000 X g for 3 min at 4°C. Each cytoplasmic fraction (3 
ul), or 3 ul of 1:10 diluted fraction of 10~5 M forskolin-treated cells 
was used for reverse transcription followed by PCR amplification as 
described previously [17]. All results are given as mean of three in-
dependent experiments performed in triplicate wells ± SEM. Levels of 
significance were calculated by the Student's t test (P < 0.05 was con-
sidered significant; NS, non-significant). 
2.5. Transfection analysis 
The transfected plasmids were constructed as follows: the human 
renin gene promoter fragments were excised from pGL2 reporter plas-
mids and fused with the luciferase reporter gene of pGL3-basic (Prom-
ega) [8]. Intron A of the human renin gene was amplified by PCR 
from a genomic clone for 30 cycles using the Expand high fidelity kit 
(Boehringer Mannheim) using the primers 5'-TCCTGTACCTTTGG-
TCTCCCGACA-3' and 5'-ATCACCTCTGTCACTGAGGGCCTC-
3'. The PCR product was subcloned into the pCRII.l vector (Invi-
trogen) and Intron A was then subcloned in the forward orientation 
upstream of the luciferase gene in pGL3basic at the KpnXIXbal sites 
creating pGL3-Intron A. The promoter fragments controlling lucifer-
ase expression of pGL3-582, pGL3-892 and pGL3-2824 plasmids were 
subcloned downstream of Intron A by Bgäl/Kasl digestion creating 
pGL3-582-Intron A, pGL3-892-Intron A, and by XhollKasl digestion 
creating pGL3-2824-Intron A. Intron A was excised from the pGL3-
Intron A vector by KpnllXhol digestion and subcloned in the forward 
orientation upstream the SV40 promoter of the pGL3-promoter vec-
tor (Promega), allowing the comparison of pGL3-SV40 and pGL3-
SV40-Intron A activities. All constructions were verified by the di-
deoxy sequencing method (Sequenase Version 2.0, DNA sequencing 
kit, USB). 
Transient DNA transfections were performed using Dosper liposo-
mal transfection reagent (Boehringer Mannheim). Calu-6, Hela and 
CHO cells were plated in 12-well plates and the culture medium was 
replaced by serum-free medium shortly before transfection. Dosper/ 
DNA mixture, consisting of 6 ug of Dosper plus 1.5 ug renin reporter 
construct and 50 ng RSVCAT (as an internal control for plate-to-
plate transfection efficiency), was then added. After overnight incuba-
tion, the medium was replaced with supplemented medium or serum-
free medium when testing the effect of forskolin. In the latter case, the 
cells were then incubated for 24 h in the presence or absence of 10~5 
M forskolin. Transfected cells were washed 3 times with PBS, lysed by 
adding 100 ul of passive lysis buffer (Promega). Luciferase activity 
was estimated by measuring luminescence for 10 s with a Bio.Orbit 
1250 luminometer, 1 min after addition of 50 ul of luciferase reporter 
buffer (Promega). 
Quantitative determination of chloramphenicol acetyl transferase 
(CAT) was performed by a sandwich immunoassay (Boehringer 
Mannheim). 
All results are given as the mean of at least three independent 
transfection experiments ±SEM. Levels of significance were calcu-
lated by Student's t test (P<0.05 was considered significant; NS, 
non-significant). 
3. Results and discussion 
Even though the main site of human renin synthesis is the 
juxtaglomerular cells of the kidney, renin gene expression has 
also been reported in a few malignant pulmonary tumors [10-
12]. Until now, the extra-renal model, chorionic cells, have 
been used to determine human renin secretion and transcrip-
tional regulation [17], to delineate the cis-regulatory elements 
of the proximal promoter [7] and to determine the sequences 
binding trans-acting factors responsible for cAMP induction 
of the transcription of the human renin gene promoter [8]. 
Recently, Lang et al. [13] described that Calu-6, a cell line 
isolated from a human anaplastic pulmonary carcinoma ex-
pressed the human renin gene. It was therefore interesting to 
compare renin gene expression and renin gene regulation in 
both cell types. 
3.1. Characterization of Calu-6 cells 
First, we characterised renin gene expression in Calu-6 cells. 
The average production of renin (prorenin and renin) in early 
passages (passage 36 to 47) was 5 ng/ml/24 h. By comparison, 
human chorionic cells in primary cultures produced 30-50 ng/ 
ml/24 h, which is at least 3 times the highest rate produced by 
Calu-6 cells. In addition, our results demonstrated that renin 
synthesis falls to a very low level (0.9 ng/ml/24 h) around 
passage 48 in Calu-6 cells and accordingly, all our experiments 
were performed before this passage. Intracellular renin repre-
sents less than 5% of the total renin produced by Calu-6 cells. 
Immunofluorescence studies performed with the polyclonal 
antibody R15, which recognizes both renin and prorenin, 
also showed that there is no storage in these cells, as only a 
weak renin immunoreactivity was observed in basal culture 
conditions (Fig. 1A), whereas no staining was detected with 
the preimmune serum (data not shown). In conclusion, Calu-6 
cells are an established cell line which represent a useful model 
for human renin gene expression studies, as long as experi-
ments are restricted to early passages. 
3.2. Human renin gene proximal promoter activity 
To characterise cis-acting elements of the proximal pro-
moter necessary for basal transcription, we performed transi-
ent transfection analysis of different renin promoter lengths 
fused to a luciferase reporter gene in Calu-6 cells. Transfection 
efficiency was verified by plate-to-plate co-transfection with 
RSVCAT. In addition, a higher transfection efficiency of 
Calu-6 was observed compared to chorionic cells. Our results 
demonstrate that pGL3-582, which contains the fragment 
—582 to +16 has the highest promoter activity in Calu-6 cells 
(Fig. 2). Therefore, results were expressed as percentage of its 
activity. Transfection of the pGL3-145 plasmid showed that 
its activity was 80% compared to pGL3-582. In addition, no 
potent enhancers seem to be present in the proximal promoter 
up to -2824 since the pGL3-2824 plasmid had 50% activity as 
compared to pGL3-582. These results are in good accordance 
with those previously reported by Lang et al. [13] who showed 
that maximal activity was reached by transfecting the —896 
construct, whereas the —148 and —2750 exhibit respectively 
80 and 60% of the activity of the —896 plasmid. In chorionic 
cells, pGL3-145 had 150% activity and pGL3-2824 did not 
show any statistically different activity (both compared to 
pGL3-582), suggesting a slightly differential regulation of the 
human renin gene proximal promoter in both cell types. Se-
quences of the human renin proximal promoter required for 
basal activity have been precisely defined in chorionic cells by 
transfecting a series of chimeric genes in which nucleotides 
corresponding to the cAMP responsive element (CRE) 
(-234 to -214) and to the site (-77 to -67) , which does 
not bind to Pit-1 site despite bearing homology with a Pit-1 -
binding site, were mutated [8]. Transfection of these mutant 
plasmids demonstrated that the CRE and the (—77 to —67) 
region are essential for basal activity of the human renin gene 
proximal promoter in Calu-6 cells. pGL3-145Al, where the 
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to pGL3-582Al resulted in a strong loss of activity as com-
pared to the native pGL3-582. In addition, disruption of the 
CRE (-226 to -219) in pGL3-582MUT to a site that no 
longer binds CRE-binding protein (CREB), as described pre-
viously [8] allowed to create pGL3-582MUT. This mutated 
construct had -35% of the activity of the wild-type pGL3-
582 construct. Finally, all promoter activity was completely 
abolished by transfecting the pGL3-582AlMUT where both 
the CRE and the (—77 to —67) region are mutated. 
Fig. 1. Immunofluorescence photomicrographs of human Calu-6 
cells in culture. Specific cytoplasmic staining with renin antiserum 
(R15) of non-treated cells (A) or 10~6 M forskolin-treated cells (B). 
consensus binding site for Pit-1 (—77 to —67) was replaced by 
the Al mutation [23] lost all activity and is comparable to 
pGL3-basic. Mutation of this region in pGL3-582, leading 
3.3. Intron A contains cis-regulatory elements 
In mammalian genes, gene expression is regulated by multi-
ple cw-acting elements which are present in the promoter, 
whether distal or proximal, but also within regions of the 
gene including introns and 3Ö untranslated regions. Among 
them, it has been shown for several genes that regulatory 
sequences are present in the first intron. To identify the role 
of Intron A [24] on the transcription rate of the human renin 
gene driven by the proximal promoter, its sequence was in-
serted in the forward orientation in pGL3-basic and upstream 
the renin promoter fragment in the pGL3-582, pGL3-892, 
pGL3-2824 constructs, creating respectively pGL3-582-Intron 
A, pGL3-892-Intron A, pGL3-2824-Intron A. Calu-6 cells 
were transiently transfected with an equal mass (1.5 (xg) or 
an equimolar amount (6.5 fmol) of each construct, the same 
results were obtained whatever the protocol we used and it 
was verified that Intron A showed no significant effect on 
pGL3-basic. Our results showed that the presence of Intron 
A, which was inserted upstream and in the sense orientation, 
was associated with a repression of activity directed by the 
(—582 to +16) and the (—892 to +16) fragments and a weaker 
effect on the (-2824 to +16) (Fig. 3). Intron A had the highest 
inhibitor effect on the (—892 to +16) fragment. This result 
demonstrates that Intron A has a transcriptional silencing 
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Fig. 2. Analysis of different renin promoter/luciferase constructs transfected into Calu-6 cells. Results (mean ± SEM) are given as percentage of 
pGL3-582 luciferase activity. The CRE (CGTCA) was mutated to tcgga and the Pit-1 binding site core sequence TAATAAATCAG was re-
placed by TAATgggcGcG as previously described. Each box represents the results of three independent transfection experiments performed in 
triplicate flasks. Levels of significance were calculated by the Student's t test. Groups, significantly different (P < 0.05) from each other are indi-
cated by various location keys (*,t,*,§). 
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Fig. 3. Analysis of different renin promoter-Intron A/luciferase constructs transfected into Calu-6 cells. Results (mean ± SEM) are given as per-
centage of pGL3-582 luciferase activity. Each box represents the results of three independent transfection experiments performed in triplicate 
wells. Levels of significance were calculated by the Student's / test. 'Significantly different from control (without intron) (P<0.05). NS, non-sig-
nificant. 
activity independent of its orientation and of its insertion site. 
Recently, during the course of this study, Lang et al. [19] 
showed a decrease in transcriptional activity which occurred 
in an orientation independent manner and that sequences be-
tween — 149 and —896 may be required for the full silencing 
effect of Intron A when it was inserted downstream from the 
human renin promoter fragments. Intron A was also inserted 
upstream the SV40 promoter contained in pGL3-promoter 
vector to check for potential promoter specificity of the silenc-
ing effect of intron A. Our results show that intron A also 
displays a comparable silencing effect on the activity of the 
SV40 promoter when transfected in renin-producing Calu-6 
cells (Fig. 4A). In the context of this heterologous promoter, 
the silencing effect occurs in the same order of magnitude than 
the one observed on the (—892 to +16) fragment of the hu-
man renin promoter. Similarly, a cell-specific negative regula-
tory element has been identified in the first intron of the gene 
for bovine elastin [25]. To verify if any cell-specificity occurred 
in the silencing effect of intron A, the SV40-intron A construct 
was transiently transfected in non-renin-producing cells such 
as Hela and CHO cells. Interestingly, these results show that 
intron A has a positive regulatory effect in these cells (Fig. 
4B,C) suggesting that the silencing effect is specific to renin-
producing cells. 
To determine more precisely the silencing properties of In-
tron A, we tested its effect in the presence (Fig. 3) or in the 
absence of FCS in the culture medium. We could observe 
that, in absence of FCS, renin promoter/luciferase constructs 
containing Intron A completely lost any promoter activity 
(data not shown). This suggests the presence of a putative 
regulatory element depending on the presence of FCS in the 
culture medium. This repression and serum dependence could 
be due to a down-regulation via chromatin constraints on the 
access of trans-acting factors, or at the level of interaction 
with the promoter, where the silencing elements compete for 
control of the transcription machinery. 
3.4. Cyclic AMP regulation 
The influence of cAMP on the regulation of human renin 
expression in Calu-6 cells was then studied. At the protein 
level, renin production was increased by forskolin, as shown 
by the strong renin immunostaining observed in the cytoplasm 
of treated cells (Fig. IB) compared to cells grown in basal 
conditions. This was correlated with the dose-dependent in-
crease in renin secretion. As shown in Fig. 5, forskolin in-
duced a dose-dependent stimulation of renin production in 
culture medium. In the same experiments, renin mRNA was 
measured by quantitative RT/PCR and forskolin-induced 
stimulation of renin mRNA synthesis in the same dose-de-
pendent manner. Maximum effect was observed at 10~5 M 
forskolin, whereas no effect could be detected between 10~8 
M and 10~10 M. Our results clearly confirm that, as in other 
described human renin-producing cells, forskolin is a potent 
inducer of endogenous renin gene expression. Interestingly, 
this effect differs from that observed in chorionic cells by Car-
off et al. [17] where forskolin alone had no effect on renin 
mRNA by quantitative RT/PCR, as it had also been observed 
by Duncan et al. [26] using Northern blot techniques. Never-
theless, forskolin acted synergistically with 12-myristate 13-
acetate phorbol to increase renin mRNA levels and renin 
secretion in chorionic cells [17]. The regulation by forskolin 
in Calu-6 resembles to that observed by Delia Bruna et al. [18] 
in primary cultures of mouse JG cells where forskolin stimu-
lated renin mRNA level and renin secretion. These observa-
tions suggest that, in this respect, Calu-6 cells, when compared 
to JG cells, represent a good model to study the renin gene 
regulation by forskolin. 
In addition, it has been shown, by us and others, on human 
[8] and mouse renin genes [27], that the renin proximal pro-
moter can confer cAMP responsiveness. Recent results dem-
onstrated that both the CRE and the (—77 to —67) region of 
the human renin gene are necessary to confer this inducibility 
in chorionic cells. In Calu-6 cells, a previous report by Lang et 
al. [19], was in contradiction with our results, showing that 
treatment of Calu-6 cells with 10~5 M forskolin caused a 100-
fold increase in endogenous renin mRNA but did not increase 
the renin proximal promoter activity in transient transfec-
tions. They suggested that the increase in renin mRNA by 
cAMP may be mediated by post-transcriptional mechanisms. 
However, all transient transfections were performed in the 
presence of FCS containing medium, which could explain 
why they could not observe a statistical stimulation of pro-
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Fig. 4. Analysis of SV40 promoter-Intron A/luciferase constructs transfected into Calu-6 (A), Hela (B) and CHO (C) cells. Results (mean± 
SEM) are given as percentage of pGL3SV40 promoter luciferase activity. Each box represents the results of four independent transfection ex-
periments performed in triplicate wells. Levels of significance were calculated by the Student's t test. 'Significantly different from control (with-
out intron) (P < 0.05). NS, non-significant. 
moter activity by forskolin, because FCS has been shown to 
be able to stimulate the transcription of several genes via 
different serum responsive elements [28]. In our case, we al-
ways examined the activity of these constructs after 10~5 M 
forskolin treatment in serum-free culture medium. Our results 
show that forskolin treatment induces a 2.5-fold increase in 
transcription of the pGL3-2824 construct (Table 1). This re-
sult was confirmed by showing an increase in transcription of 
the pGL3-892 and pGL3-582 constructs and further demon-
strates that the proximal promoter contains c«-acting ele-
ments directing forskolin-induced transcriptional activation. 
These results show that as in chorionic cells, the proximal 
promoter could confer cAMP responsiveness with the same 
order of magnitude [7]. In order to delineate these functional 
cw-acting sequences, we transfected pGL3-582MUT where the 
renin CRE spanning the region (—226 to —219) was mutated. 
This mutation reduced the basal activity to 35% and com-
pletely abolished the forskolin stimulation (Table 1). This re-
sult differs from that observed in chorionic cells where the 
same mutation of the CRE only diminished the basal activity 
to a minor extent and did not suppress the forskolin stimula-
tion. Therefore we examined the forskolin-induction activity 
of the (—77 to —67) region which has been shown to be 
partially responsible of the cAMP induction in chorionic cells 
[8]. By transfecting the pGL3-145 plasmid we showed that this 
sequence could confer a stimulation (1.6-fold) which was abol-
ished by the mutation of the (—77 to —67) element to a Al 
site (Table 1). In addition, in the context of the pGL3-582 
plasmid the only mutation of this region abolished the induc-
tion whereas the basal activity was only 40% reduced. Re-
cently, the same group [19,20], showed contradictory results 
concerning forskolin stimulation of the human renin gene 
promoter in Calu-6 cells. Surprisingly, in the latter paper, 
these authors observe that forskolin caused a 2-3-fold activa-
tion of the renin promoter involving both CRE-dependent 
and CRE-independent mechanisms. In summary, we conclude 
that whereas both elements can confer a part of the forskolin 
response in chorionic cells, disruption of either one element 
completely disrupt the forskolin response suggesting a differ-
ential regulation in Calu-6 cells than those reported by us and 
others [8,27] along the renin gene proximal promoter using 
different cell models. The potential effect of Intron A on 
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Fig. 5. Regulation of renin mRNA (D - D) and renin production (• - •) by forskolin. Calu-6 cells were incubated for 24 h without any agents 
(c) or with increasing concentrations of forskolin. Values are expressed as a percentage of the control and represents the results of three inde-
pendent experiments performed in triplicate wells (means ± SEM). Renin determinations were performed in culture medium of the cells used for 
renin mRNA determinations. 
cAMP-induced activation of the transcription rate of renin 
promoter/luciferase reporter constructs was also studied. 
Transient transfections of Calu-6 cells were performed in se-
rum-free defined conditions with 10~5 M forskolin. Even 
though Intron A completely inhibits the promoter activity 
of the renin/luciferase constructs with which it is associated, 
in these serum-free culture conditions, despite a minimal basal 
activity, pGL3-582-Intron A, pGL3-892-Intron A and pGL3-
2824-Intron A can still be stimulated by forskolin in a range 
similar to the stimulation observed on parental constructs (not 
shown). These results suggest that Intron A does not interfere 
with the regulation by cAMP directed by the proximal pro-
moter. 
In conclusion, our results suggest that the pulmonary car-
cinoma cell line, Calu-6 cells, is an interesting model to study 
the transcriptional regulation of the human renin gene. These 
cells are the first described established cell line to synthesize 
relatively high amounts of endogenous renin and to regulate 
renin gene transcription. We show that cAMP is a potent 
activator of mRNA synthesis and renin production. Our re-
sults show a differential regulation in the proximal promoter 
as compared to chorionic cells. The CRE and the (—77 to 
—67) element are both necessary for cAMP activation but 
do not act independently since mutation of either one element 
abolishes it. A cell-specific negative regulatory element was 
determined in the first intron of the human renin gene. In 
addition, Intron A inhibits renin promoter activity of any 
tested constructs in the absence of serum and does not inter-
fere with the forskolin stimulation. This suggests the presence 
of one silencer and one putative regulatory element depending 
on the presence of serum in Intron A. In addition, we suggest 
that the 20-fold stimulation by forskolin of mRNA synthesis 
parallel to renin secretion cannot be conferred entirely by the 
proximal promoter, which only confers a 2-fold activation, 
strongly suggesting that more distant regions from the tran-
scription start site play a major role in the regulation of the 
Table 1 
Normalized luciferase activity of different renin promoter/luciferase constructs in serum-free conditions 
Renin promoter/luciferase constructs % Basal unstimulated luciferase activity of pGL3-582 construct 
pGL3-basic 
pGL3-145 
pGL3-145Al 
pGL3-582 
pGL3-582MUT 
pGL3-582Al 
pGL3-582AlMUT 
pGL3-892 
pGL3-2824 
Fold stimulation 
9± 1* 
130±13f 
9± 2* 
172 ± 
37 ± 
54 ± 
9± 2* 
153± 6* 
80 ± 81 
8* 
6« 
su 
NS 
Xl.6 
NS 
Xl.7 
NS 
NS 
NS 
Xl.8 
X2.5 
Luciferase activity is normalized to co-transfected RSVCAT activity. Each value represents the results of three independent transfection experi-
ments performed in triplicate. Results (mean ± SEM) are expressed as percentage of basal unstimulated luciferase activity of pGL3-582 plasmid. 
Fold stimulations were calculated as the ratio of normalized luciferase activity in forskolin-treated cells versus untreated cells. 
Levels of significance were calculated by the Student's t test. Groups, significantly different (P < 0.05) from each other are indicated by various 
location keys CV.V1 ,1 ,). NS, non-stimulated. 
S. Germain et allFEBS Letters 407 (1997) 177-183 
human renin transcriptional regulation. Our study demon-
strates that these cw-acting sequences mediating this activa-
tion are not located within the first intron. Molecular charac-
terisation of each of these points are currently under study 
and should provide important new insights concerning the 
regulation of the human renin gene transcription. 
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